Predictive biomarkers candidates for patients with metastatic colorectal cancer treated with bevacizumab-containing regimen
In. CASMU. Investigación clínica: desarrollo e innovación, 2019. Montevideo, Ideas Uruguay, 2019. p.315-323.
Monography
in En
| LILACS, UY-BNMED, BNUY
| ID: biblio-1359721
Responsible library:
UY1.1
Localization: UY1.1; 7A, INV 2019
Search on Google
Index:
LILACS
Main subject:
Colorectal Neoplasms
/
Biomarkers, Tumor
/
Bevacizumab
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Year:
2019
Type:
Monography